Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

E2F1 pathways to apoptosis.

Doron Ginsberg1

  • 1Department of Molecular Cell Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel. doron.ginsberg@weizmann.ac.il

FEBS Letters
|October 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: ATM is a target for positive regulation by E2F-1.

Oncogene·2025
Same author

The lincRNA JUNI regulates the stress-dependent induction of c-Jun, cellular migration and survival through the modulation of the DUSP14-JNK axis.

Oncogene·2024
Same author

Correction: The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells.

Oncotarget·2021
Same author

A novel E2F1-regulated lncRNA, LAPAS1, is required for S phase progression and cell proliferation.

Oncotarget·2021
Same author

Theileria parasites subvert E2F signaling to stimulate leukocyte proliferation.

Scientific reports·2020
Same author

In Vitro Evaluation of Chemically Analyzed <i>Hypericum Triquetrifolium</i> Extract Efficacy in Apoptosis Induction and Cell Cycle Arrest of the HCT-116 Colon Cancer Cell Line.

Molecules (Basel, Switzerland)·2019
Same journal

Identification of a Shiga toxin A-derived peptide internalized into Gb3 receptor-bearing cells via interaction with the Shiga toxin B subunit.

FEBS letters·2026
Same journal

The dual role of lectins in cancer-immunotherapy tools and therapeutic targets.

FEBS letters·2026
Same journal

Decoding the dynamic extracellular matrix in cancer-3D models and bioscaffolds rewire the rules of tumor progression.

FEBS letters·2026
Same journal

Extending the classical sequence-structure-function paradigm through protein dynamics and context-dependent behavior.

FEBS letters·2026
Same journal

α-Synuclein aggregation landscape from phase separation to neurotoxic intermediates.

FEBS letters·2026
Same journal

Modelling stem cell differentiation related processes-A practical overview for biologists.

FEBS letters·2026
See all related articles

The E2F1 transcription factor regulates cell growth and can trigger apoptosis, a programmed cell death. Its deregulation in cancer may act as a safeguard, eliminating pre-malignant cells and preventing tumor development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The E2F family of transcription factors is crucial for controlling cell proliferation.
  • Dysregulation of E2F activity is frequently observed in human cancers.
  • E2F1 has a dual role, capable of promoting both cell proliferation and apoptosis.

Purpose of the Study:

  • To elucidate the role of E2F1 in cell proliferation and apoptosis.
  • To investigate the pathways through which E2F1 induces apoptosis, including its relationship with p53.
  • To understand the implications of E2F1 deregulation in the context of oncogenic stress and tumor suppression.

Main Methods:

  • Analysis of E2F1's function in cell proliferation.
  • Investigation of E2F1-induced apoptotic pathways.

Related Experiment Videos

  • Examination of the interaction between E2F1 and the tumor suppressor p53.

    • Main Results:

    • E2F1 can induce both cell proliferation and apoptosis.
    • E2F1-mediated apoptosis involves pathways that stabilize and activate the tumor suppressor p53.
    • The pro-apoptotic function of E2F1 was demonstrated.

    Conclusions:

    • E2F1's pro-apoptotic activity suggests a tumor-suppressive role.
    • Deregulation of E2F1 may act as oncogenic stress, initiating apoptosis in pre-malignant cells.
    • This mechanism could prevent tumor development by eliminating cells with oncogenic potential.